Cairo – Mubasher: Alexandria Pharmaceuticals and Chemical Industries said it targets an increase of 22.5% in net profits for the fiscal year 2016/17.
The drug firm eyes net profits of EGP 63.75 million in FY16/17, up from EGP 52 million in FY14/15.
Alexandria Pharmaceuticals saw net profits of EGP 34.1 million for the first half of FY15/16.
